LWLeyu Wang

Leyu Wang

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Leyu Wang has a total of 123 co-authors. Here are the top co-authors by number of shared publications:

  • Xiaozhong Qiu

    Guangdong Provincial Key Laboratory of Construction and Detection in Tissue Engineering, Department of Anatomy, School of Basic Medical Sciences, Southern Medical University, Guangzhou, Guangdong, China

    7 shared publications
  • Chen Song

    Department of Neurology Institute of Neuroscience The Second Affiliated Hospital Guangzhou Medical University Guangzhou China

    5 shared publications
  • Malcolm Xing

    University of Manitoba

    4 shared publications
  • Xiaozhong Qiu

    Guangdong Provincial Key Laboratory of Construction and Detection in Tissue Engineering, School of Basic Medical Science, Southern Medical University, Guangzhou, Guangdong 510515, P.R. China

    4 shared publications
  • Genlan Ye

    Southern Med Univ, Sch Basic Med Sci, Guangdong Prov Key Lab Construct & Detect Tissue, Biomat Res Ctr,Sch Biomed Engn, Guangzhou 510515, Guangdong, Peoples R China

    3 shared publications
  • Junjie Liu

    Biomaterials Research Center, School of Biomedical Engineering, Southern Medical University, Guangzhou, China

    3 shared publications

Latest Publications

  • Open Access

    Chlorophyll as a sustainable crosslinking strategy for engineering highly compressible hydrogels

    by Kaige Xu, Chaoran Zhao, Yuqing Liu, Junjie Liu, Xianglong Xing, Oluwaloba Wisdom Ojo, Mingsong Wu, Quan Wang, Malcolm M. Q. Xing, Leyu Wang

  • Open Access

    Chuanxiong Extract‐Decorated Mitochondria‐Targeted Nanocarriers Attenuate Infarct Injury by Restoring Mitochondrial Homeostasis and Blocking Oxidative Cascade

    by Qinran Chen, Yaxi He, Guangbing Luo, Xin Zhang, Jie Shen, Danfeng Wu, Yutong He, Bingyu Zhao, Leyu Wang, Renjie Qiu

    The complex phytochemical composition of Traditional Chinese Medicines (TCM) like Ligusticum chuanxiong offers multi‐target therapeutic potential, yet their intracellular mechanisms remain largely undefined due to a lack of suitable investigative tools. We report a mitochondria‐targeted nanoformulation (NSCE) created by loading Chuanxiong extract (CE) into amino‐functionalized mesoporous silica nanoparticles (NS). We show that the adsorbed extract components unexpectedly confer mitochondrial tropism to the simple amino‐functionalized silica nanoparticles, a function not inherent to the unmodified carrier. In vitro, NSCE selectively localizes to the mitochondria of cardiomyocyte, mitigating oxidative stress and dysfunction more effectively than free CE. In a rat model of ischemia/reperfusion injury, intramyocardial NSCE injection reduces infarct size and improves cardiac function. Mechanistically, NSCE synergistically modulates p53 and PI3K/AKT pathways to suppress apoptosis and oxidative stress, an action linked to its delivery of 52 identified bioactive constituents. This work introduces a paradigm where a complex herbal extract can functionalize a simple nanocarrier for organelle‐specific delivery, offering a tractable strategy to dissect and harness the multitarget pharmacology of traditional medicines.

  • Open Access

    Pseudocapacitive Charge‐Driven Adhesive‐Electrocoupling Hydrogels for Myocardial Infarction Repair via Interstitial Microenvironment Remodeling

    by Shengxi Jiang, Huijia Nong, Chen Song, Yujia Zheng, Peiji Yang, Huabin Liu, Dongyi Feng, Yuhuizi Han, Mohan Wang, Lili Jiang, et al.

    Myocardial infarction (MI) creates a hostile microenvironment characterized by oxidative stress, inflammation, fibrosis, and electrical conduction block, posing a multifaceted challenge for tissue repair. To address this, we developed a multifunctional hydrogel (Gel‐PDZC), through an artificial neural network (ANN)‐guided optimization process, incorporating nanoparticles comprising a ZIF‐8@CaO 2 core for sustained oxygen release, a polydopamine (PDA) interlayer for adhesion and antioxidant activity, and a conductive poly(3,4‐ethylenedioxythiophene) (PEDOT) shell. The hydrogel exhibits a unique “adhesion‐electrocoupling” effect, where robust tissue adhesion facilitates a pseudocapacitive charge injection mechanism. This not only enables active electrical intervention in the avascular scar but also leverages the endogenous myocardial electric field to restore the hydrogel's antioxidant properties. In a rat MI model, the Gel‐PDZC hydrogel comprehensively remodeled the myocardial interstitial microenvironment. It alleviated hypoxia, reduced oxidative stress and apoptosis, suppressed pro‐inflammatory C‐C motif chemokine receptor 2 (CCR2 + ) macrophages recruitment and promoted electrical coupling between resident CCR2 − macrophages and cardiomyocytes (CMs), inhibited fibroblast‐to‐myofibroblast transition via the PI3K/AKT pathway, and stimulated angiogenesis. These coordinated cellular and molecular changes translated into substantial functional recovery, evidenced by restored epicardial electrical propagation, improved electromechanical coupling, and a significant increase in cardiac function. Our findings demonstrate that this ANN‐optimized, adhesive‐electrocoupling hydrogel provides a comprehensive and synergistic solution for repairing the infarcted heart.


  • Open Access

    Bioactive Magnesium Silicate Activating Myocardial Energy Metabolism For Infarcted Myocardium Repair

    by Zhibin Liao, Chen Qin, Erhong Song, Chengbin Ding, Zhixu Wang, Yan Sun, Chen Song, Junjie Liu, Jingge Ma, Hongjian Zhang, et al.

    The heart is a highly energy‐dependent organ, developing bioenergy‐activating biomaterials to activate myocardial adenosine triphosphate (ATP) production and restore dysregulated energy homeostasis is a promising solution for its functional recovery. Inorganic biomaterials with tunable properties may deliver multiple physicochemical cues for bioenergy‐activation. However, there is currently a lack of systematic design and study on inorganic biomaterials‐derived physicochemical cues for myocardial bioenergy‐activation. This study proposes a bioenergy‐activating bioink based on inorganic biomaterials. Through the dual design of the chemical composition and physical morphology cues, the bioinks containing magnesium silicate (MS) nanoparticles with different morphologies were developed, and the corresponding 3D bioprinted cardiac patches were prepared. It was found that the magnesium and silicon components of MS are well beneficial to ATP production and myocardial maturation. More importantly, the morphology of MS nanoparticles could regulate the mitochondria‐targeted effects after endocytosis and the dynamic stiffness of the hydrogel matrix, thus systematically modulating ATP production and myocardial function. Furthermore, the patches with MS nanotubes significantly promoted heart repair and functional recovery in both rat and minipig animal models. This study proposes a new bioink design strategy based on biocompatible inorganic biomaterials for bioenergy‐activation to promote heart repair, offering more potential avenues for the clinical treatment of damaged, complex tissue.


  • Multiscale anisotropic scaffolds enable a biomimetic electro-mechanical myocardial platform for drug discovery and heart repair

    by Jianyong Zou, Jiarong Zhang, Qiuyuan Zhao, Guangbing Luo, Xin Zhang, Shuhui Chen, Yanyan Li, Yutong He, Leyu Wang, Xiaozhong Qiu

    Engineered cardiac microtissues on multiscale anisotropic scaffolds enhance contraction, enable high-sensitivity drug response, and improve cardiac function post-MI.


  • Open Access

    Bioceramics-enhanced patch activates epicardial epithelial-to-mesenchymal transition via Notch pathway for cardiac repair

    by Chengbin Ding, Chen Qin, Yan Sun, Yueyang Liu, Guofeng Tang, Zhibin Liao, Chaoran Zhao, Chengtie Wu, Leyu Wang

    Engineered cardiac patches (ECPs) introduced functional factors that offer a promising strategy for the treatment of myocardial infarction (MI). Silicate bioceramics have received widespread attention because of their great potential in the tissue repair field. Inspired by the biological functions of inorganic ions on the cardiovascular system, we prepared an ECP containing lithium magnesium silicon bioceramics (LMS) particles. The release of multiple bioactive ions from LMS-containing ECPs could facilitate the functionalization and intercellular communication between cardiomyocytes (CMs). Furthermore, it was demonstrated that the LMS-containing ECPs could promote epicardial cell epithelial-to-mesenchymal transition (EMT) through the Notch pathway and paracrine, which efficiently repaired damaged CMs. In vivo, the regenerative microenvironment induced by LMS-containing ECPs restored normal electrical impulse propagation across scar tissue, activated islands of surviving myocardium, and improved cardiac function. Overall, this study constructed a bioceramics-enhanced ECP, which could promote cardiac repair by activating epicardial EMT, providing a promising strategy for MI repair.


  • Novel paper sensor with modified aptamer for accurate detection of clinical cardiac troponin I

    by Qing Xie, Danfeng Wu, Qinran Chen, Haiyan Liang, Leyu Wang, Xiaozhong Qiu

    Accurate and rapid detection of Cardiac Troponin I (CTnI) is essential for the early diagnosis and timely management of myocardial infarction (MI). However, conventional detection methods relying on antigen–antibody interactions often face challenges such as high costs and lengthy procedures. Novel detection methods based on antigen–aptamer interactions offer a potentially superior alternative. Nevertheless, the performance of antigen–aptamer sensors is typically compromised by the unstable structure of aptamers, resulting in limited sensitivity and inconsistent specificity in CTnI detection. To address these issues, we have developed an innovative aptamer structure to construct a paper-based sensor comprising a paper electrode and a CTnI aptamer detection module. The paper electrode employs PEDOT:PSS to uniformly distribute single-walled carbon nanotubes (SWCNTs) at high concentrations on filter paper. The detection module utilizes modified CTnI aptamers with a continuous (AT)5 sequence in the anchor domain to enhance stable immobilization on SWCNTs without chemical reactions. We discovered that incorporating appropriate 18-atom hexa-ethylene glycol spacers (Sp18) between the protein-capture and anchor domains of the aptamers can improve the sensitivity of the current response for CTnI detection. Through the optimization of annealing temperature and duration, the paper sensor Aps3-CTnI-PS@CP, which integrates (AT)5 and three Sp18 into the aptamer, demonstrated enhanced sensitivity and specificity for CTnI detection. When applied to clinical samples, Aps3-CTnI-PS@CP exhibited a favorable receiver operating characteristic (ROC) curve, with an area under the curve (AUC) of 0.982, a sensitivity of 0.917, and a specificity of 0.945 for CTnI detection. This performance correlates strongly with traditional chemiluminescence immunoassay (CLIA) assays used in clinical settings. The straightforward fabrication process and minimal batch-to-batch variability make Aps3-CTnI-PS@CP a promising candidate for clinical aptamer-based CTnI detection.


  • Open Access

    A functional cardiac patch promotes cardiac repair by modulating the CCR2− cardiac-resident macrophage niche and their cell crosstalk

    by Chengbin Ding, Guofeng Tang, Yan Sun, Xiaodong Fu, Ye Tian, Jiamian Zhan, Songtao Zhang, Xianglong Xing, Jianing Liu, Xiaozhong Qiu, et al.


  • Open Access

    Cardiac organ chip: advances in construction and application

    by Jun Li, Honghao Hou, Qian Li, Junjie Liu, Yunlong Zhao, Chaoran Zhao, Zhentao Li, Leyu Wang, Xiaozhong Qiu

    Cardiovascular diseases are a leading cause of death worldwide, and effective treatment for cardiac disease has been a research focal point. Although the development of new drugs and strategies has never ceased, the existing drug development process relies primarily on rodent models such as mice, which have significant shortcomings in predicting human responses. Therefore, human-based in vitro cardiac tissue models are considered to simulate physiological and functional characteristics more effectively, advancing disease treatment and drug development. The microfluidic device simulates the physiological functions and pathological states of the human heart by culture, thereby reducing the need for animal experimentation and enhancing the efficiency and accuracy of the research. The basic framework of cardiac chips typically includes multiple functional units, effectively simulating different parts of the heart and allowing the observation of cardiac cell growth and responses under various drug treatments and disease conditions. To date, cardiac chips have demonstrated significant application value in drug development, toxicology testing, and the construction of cardiac disease models; they not only accelerate drug screening but also provide a new research platform for understanding cardiac diseases. In the future, with advancements in functionality, integration, and personalised medicine, cardiac chips will further simulate multiorgan systems, becoming vital tools for disease modelling and precision medicine. Here, we emphasised the development history of cardiac organ chips, highlighted the material selection and construction strategy of cardiac organ chip electrodes and hydrogels, introduced the current application scenarios of cardiac organ chips, and discussed the development opportunities and prospects for their of biomedical applications.


  • Open Access

    E-cardiac patch to sense and repair infarcted myocardium

    by Renjie Qiu, Xingying Zhang, Chen Song, Kaige Xu, Huijia Nong, Yi Li, Xianglong Xing, Kibret Mequanint, Qian Liu, Quan Yuan, et al.

    Conductive cardiac patches can rebuild the electroactive microenvironment for the infarcted myocardium but their repair effects benefit by carried seed cells or drugs. The key to success is the effective integration of electrical stimulation with the microenvironment created by conductive cardiac patches. Besides, due to the concerns in a high re-admission ratio of heart patients, a remote medicine device will underpin the successful repair. Herein, we report a miniature self-powered biomimetic trinity triboelectric nanogenerator with a unique double-spacer structure that unifies energy harvesting, therapeutics, and diagnosis in one cardiac patch. Trinity triboelectric nanogenerator conductive cardiac patches improve the electroactivity of the infarcted heart and can also wirelessly monitor electrocardiosignal to a mobile device for diagnosis. RNA sequencing analysis from rat hearts reveals that this trinity cardiac patches mainly regulates cardiac muscle contraction-, energy metabolism-, and vascular regulation-related mRNA expressions in vivo. The research is spawning a device that truly integrates an electrical stimulation of a functional heart patch and self-powered e-care remote diagnostic sensor.